Search Results - "Burdach, Stefan E."

Refine Results
  1. 1

    Current State of Immunotherapy and Mechanisms of Immune Evasion in Ewing Sarcoma and Osteosarcoma by Evdokimova, Valentina, Gassmann, Hendrik, Radvanyi, Laszlo, Burdach, Stefan E G

    Published in Cancers (30-12-2022)
    “…We argue here that in many ways, Ewing sarcoma (EwS) is a unique tumor entity and yet, it shares many commonalities with other immunologically cold solid…”
    Get full text
    Journal Article
  2. 2

    DNA Microarrays reveal relationship of ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets by STAEGE, Martin S, HUTTER, Christoph, NEUMANN, Ingo, FOJA, Sabine, HATTENHORST, Uwe E, HANSEN, Gesine, AFAR, Danny, BURDACH, Stefan E. G

    Published in Cancer research (Chicago, Ill.) (15-11-2004)
    “…Ewing family tumors (EFTs) are small round blue cell tumors that show features of neuroectodermal differentiation. However, the histogenetic origin of EFTs is…”
    Get full text
    Journal Article
  3. 3

    Precision medicine in pediatric oncology by Burdach, Stefan E. G., Westhoff, Mike-Andrew, Steinhauser, Maximilian Felix, Debatin, Klaus-Michael

    Published in Molecular and cellular pediatrics (31-08-2018)
    “…Outcome in treatment of childhood cancers has improved dramatically since the 1970s. This success was largely achieved by the implementation of cooperative…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Cleavage of the Ewing Tumour-specific EWSR1-FLI1 mRNA by Hammerhead Ribozymes by HÜHN, Regina, STAEGE, Martin S, HESSE, Manuela, LIEBIG, Beate, BURDACH, Stefan E. G

    Published in Anticancer research (01-06-2009)
    “…Background: Ewing family tumours (EFT) are the second most common bone tumours in children and adolescents. In the majority of EFT, EWSR1-FLI1 (Ewing sarcoma…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Abstract 5000: YB-1 based oncolytic virotherapy in combination with small molecular inhibitors for treatment of refractory osteosarcoma by Middendorf, Charlotte Friederike, Schober, Sebastian Johannes, Kordass, Corazón, Nawroth, Roman, Burdach, Stefan E., Holm, Per Sonne, Thiel, Uwe

    Published in Cancer research (Chicago, Ill.) (15-08-2020)
    “…This in vitro study evaluates YB-1 based oncolytic virotherapy in combination with molecular target therapy as a novel therapeutic strategy for refractory…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Donor lymphocyte infusions in adolescents and young adults for control of advanced pediatric sarcoma by Schober, Sebastian J, von Luettichau, Irene, Wawer, Angela, Steinhauser, Maximilian, Salat, Christoph, Schwinger, Wolfgang, Ussowicz, Marek, Antunovic, Petar, Castagna, Luca, Kolb, Hans-Jochem, Burdach, Stefan E G, Thiel, Uwe

    Published in Oncotarget (27-04-2018)
    “…Allogeneic stem cell transplantation (allo-SCT) and donor lymphocyte infusions (DLI) may induce a graft-versus-tumor effect in pediatric sarcoma patients…”
    Get full text
    Journal Article
  17. 17

    A costimulatory chimeric antigen receptor targeting TROP2 enhances the cytotoxicity of NK cells expressing a T cell receptor reactive to human papillomavirus type 16 E7 by Poorebrahim, Mansour, Quiros-Fernandez, Isaac, Marmé, Frederik, Burdach, Stefan EG, Cid-Arregui, Angel

    Published in Cancer letters (10-07-2023)
    “…Immune cells modified to express a tumor-reactive T cell receptor (TCR) have shown limited efficacy as stand-alone therapy against solid tumors. Genital and…”
    Get full text
    Journal Article
  18. 18

    Abstract B058: Clusterin overexpression in therapeutic T cell induces resistance to exhaustion by Segner, Constantin, Kolesnikova, Alisa, Poorebrahim, Mansour, Höbart, Julia, Schulz, Miriam, Xue, Busheng, Brückner, Christian, Madeira, Alissia Fernandes, Hauer, Julia, Ruland, Jürgen, Sorensen, Poul H., Burdach, Stefan EG

    Published in Cancer research (Chicago, Ill.) (05-09-2024)
    “…Ewing Sarcoma (EwS) is characterized by an immunosuppressive tumor microenvironment (TME), which promotes T cell exhaustion, among other factors by chronic…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Granulocyte-macrophage-colony stimulating factor for prevention of neutropenia and infections in children and adolescents with solid tumors. Results of a prospective randomized study by Burdach, S E, Müschenich, M, Josephs, W, Frisch, J, Schulz, G, Jürgens, H, Göbel, U

    Published in Cancer (01-08-1995)
    “…Chemotherapy is an essential modality of curative strategies in pediatric oncology. Dose and dose intensity are, above all, restricted by the myelosuppressive…”
    Get more information
    Journal Article